Johnson & Johnson Faces Ongoing Talc Litigation: $40 Million Awarded in Baby Powder Cancer Case

A California jury has ordered Johnson & Johnson to pay $40 million to two women who claim that decades of using the company’s talc-based baby powder led to their ovarian cancer diagnoses. The women, who testified about their extensive medical treatments, argue that the company was aware of the potential dangers of its product. Johnson & Johnson plans to appeal the verdict, asserting that the evidence does not support the jury’s decision.

Details of the Case

The lawsuit involved two California residents, who were diagnosed with ovarian cancer in 2014 and 2018, respectively. Both women reported using Johnson & Johnson’s baby powder after bathing for approximately 40 years. Their testimonies revealed the severity of their conditions, which required major surgeries and numerous rounds of chemotherapy. During the trial, their attorney, Andy Birchfield, emphasized that the company had knowledge of the risks associated with its product but chose to conceal this information from consumers. This assertion aimed to highlight the company’s alleged negligence in protecting its customers.

Johnson & Johnson’s Defense

In response to the claims, Johnson & Johnson’s attorney, Allison Brown, argued that the evidence presented in the case was insufficient. She pointed out that no major U.S. health authority supports the connection between talc and ovarian cancer, nor is there any scientific study that demonstrates talc can migrate from the skin to the reproductive organs. The company maintains that its products are safe, free from asbestos, and do not cause cancer. Erik Haas, the company’s vice president of litigation, announced plans to appeal the verdict, describing it as an “aberrant” decision that the company expects to overturn.

Ongoing Legal Challenges

Johnson & Johnson faces a significant number of lawsuits, with over 67,000 plaintiffs alleging that their use of talc products resulted in cancer diagnoses. The company halted the sale of talc-based baby powder in the U.S. in 2020, transitioning to a cornstarch alternative. Previous attempts by Johnson & Johnson to resolve these lawsuits through bankruptcy have been rejected by federal courts, with the most recent dismissal occurring in April. The cases involving the two women are the first to go to trial following these bankruptcy attempts.

Historical Context and Future Implications

Before the bankruptcy proceedings, Johnson & Johnson had a mixed record in talc-related trials, with some verdicts reaching as high as $4.69 billion awarded to women claiming their ovarian cancer was caused by the baby powder. While the company has won some trials, others have resulted in substantial judgments against it. The majority of the lawsuits focus on ovarian cancer, although a smaller number involve claims related to mesothelioma, a rare and deadly cancer. Johnson & Johnson has previously settled some mesothelioma claims but has not established a nationwide settlement, leading to ongoing trials in state courts. Recently, the company has faced significant verdicts in mesothelioma cases, including a notable judgment exceeding $900 million in Los Angeles last October.

Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.

Follow Us on Twitter, Instagram, Facebook, & LinkedIn